21 CFR 201 (drug labeling)
21 CFR Part 201: Labeling
Summary
FDA's general drug labeling regulation: name and place of business, NDC, established name and its prominence, expiration date, Rx-only symbol, bar code, prescribing information (PLR) and OTC Drug Facts.
More in the full catalogue
Key labelling requirements (4), transition and timeline notes, related documents and CSV export are available to testers.
Sign in · Register
Relevance by packaging component
| Component | Relevance | What it concerns |
|---|---|---|
| CartonOuter packaging / folding carton | D Direct | |
| LabelImmediate container label (bottle, tube, large vial, bag) | D Direct | |
| Blister / foilBlisters, strips, sachets, lidding foil | I Indirect | |
| Small unitSmall immediate packaging: ampoule, small vial, cartridge, pen | D Direct | |
| LeafletPackage leaflet / PIL, package insert, prescribing information, Medication Guide | D Direct | |
| DeviceIntegral or co-packaged device and its instructions for use | – | |
| Shipper / caseTertiary packaging: shipping case, homogeneous case, pallet | – | |
| e-LabellingElectronic product information, QR / 2D-code linked content | – |
packart.dev summary, not a quotation of the source. Confirm requirements in the official text before regulatory use.